For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | Placebo designed to mimic intervention Placebo: Placebo designed to mimic intervention | 26 | None | 3 | 64 | 9 | 64 | View |
| Intervention | Vitamin C Vitamin C: Continuous infusion of vitamin C | 16 | None | 4 | 61 | 8 | 61 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Elevated Troponin w/o ST elevation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| New or worsening heart failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Arrythmia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Bleeding | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Pancytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Loose stools | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dysphagia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| New or worsening heart failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Arrythmia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Elevated Troponin w/o ST elevation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pleural Effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Bleeding event | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Maculopapular rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |